Skip to content
HCW Biologics
  • About Us
    • Leadership and Board
  • The Science
    • TOBI™ Platform
    • Our Focus
  • Pipeline
  • News
    • News Releases
    • Publications
  • Contact
    • General Inquiries
    • Careers
  • Investors
HCW Biologics
  • About Us
    • Leadership and Board
  • The Science
    • TOBI™ Platform
    • Our Focus
  • Pipeline
  • News
    • News Releases
    • Publications
  • Contact
    • General Inquiries
    • Careers
  • Investors

Publications

A Novel Interleukin-2-Based Fusion Molecule, HCW9302, Differentially Promotes Regulatory T Cell Expansion to Treat Atherosclerosis in Mice

Frontiers in Immunology, Xiaoyun Zhu, et al., January 25th, 2023

  • Publications

Immunotherapeutic HCW9218 Augments Anti-tumor Activity of Chemotherapy via NK Cell Mediated Reduction of Therapy Induced Senescent Cells

Molecular Therapy, Chaturvedi P., et al, January 17th, 2022

  • Publications

Bifunctional TGF-β trap/IL-15 Protein Complex Elicits Potent NK Cell and CD8+ T Cell Immunity Against Solid Tumors

Molecular Therapy, Liu B. et al, October 6th 2021

  • Publications

A Fusion Protein Complex that Combines IL12, IL15, and IL18 Signaling to Induce Memory-like NK Cells for Cancer Immunotherapy

Cancer Immunol Res, Becker-Hapak M. et al., September 9th 2021

  • Publications
  • About Us
    • Leadership and Board
  • The Science
    • TOBI™ Platform
    • Our Focus
  • Pipeline
  • News
    • News Releases
    • Publications
  • Contact
    • General Inquiries
    • Careers
  • Investors

Copyright © 2021-2022 HCW Biologics Inc.